Back
GSK PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
22
GSK
GSK PLC
Last Price:
36.01
Seasonality Move:
4.3%
Sell
30
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.85
Seasonality Move:
40.93%
Sell
22
GSK PLC (GSK)
is a Sell
Is GSK PLC a Buy, Sell or Hold?
- The current GSK PLC [GSK] share price is $37.02. The Score for GSK is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- GSK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.83. The Score for ADAP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.83
The current trend is relatively stagnant and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
GSK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.91 | Sell |
| Relative Strength Index (14 RSI): | 34.93 | Sell |
| Chaikin Money Flow: | 6295081 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.34 - 39.28) | Sell |
| Bollinger Bands (100): | (38.23 - 42.11) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 48.33 | Sell |
| Chaikin Money Flow: | 444283 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.76 - 0.9) | Sell |
| Bollinger Bands (100): | (0.87 - 1.21) | Sell |
GSK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.28 | Sell |
| 20-day SMA: | 38.11 | Sell |
| 50-day SMA: | 40.49 | Sell |
| 200-day SMA: | 41.14 | Sell |
| 8-day EMA: | 37.28 | Sell |
| 20-day EMA: | 38.09 | Sell |
| 50-day EMA: | 39.4 | Sell |
| 200-day EMA: | 40.08 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.76 | Buy |
| 20-day SMA: | 0.81 | Buy |
| 50-day SMA: | 0.96 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.78 | Buy |
| 20-day EMA: | 0.82 | Buy |
| 50-day EMA: | 0.91 | Sell |
| 200-day EMA: | 1.03 | Sell |
GSK PLC Earnings Growth & GSK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.00 per share, and an increase next year of $0.33 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
GSK PLC Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||